ETF Managers Group, LLC Horizon Therapeutics Public LTD CO Transaction History

ETF Managers Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$79.4 - $116.36 $132,439 - $194,088	-1,668 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$86.42 - $109.81 $144,148 - $183,163	1,668 New	1,668 $176,000
Q3 2021 Nov 15, 2021	SELL	$91.91 - $110.37 $2.34 Million - $2.81 Million	-25,451 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$86.24 - $95.92 $1.33 Million - $1.48 Million	15,417 Added 153.65%	25,451 $2.41 Million
Q1 2021 May 17, 2021	BUY	$71.83 - $95.48 $720,742 - $958,046	10,034 New	10,034 $874,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

Stay updated on ETF Managers Group, LLC with notifications on news.